Clarity Pharmaceuticals (CU6) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Another win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancerFebruary 19 at 5:16 AM | msn.comClarity Pharmaceuticals Secures FDA Fast Track for Prostate Cancer TreatmentFebruary 18, 2025 | tipranks.comClarity Pharmaceuticals’ 64Cu-SAR-bisPSMA Receives FDA Fast Track DesignationFebruary 17, 2025 | tipranks.comClarity Pharmaceuticals Issues New Shares Under Corporations Act ComplianceFebruary 10, 2025 | tipranks.comClarity Pharmaceuticals Advances Prostate Cancer Treatment with SECuRE Trial SuccessJanuary 31, 2025 | tipranks.comClarity Pharmaceuticals (ASX:CU6) Is In A Strong Position To Grow Its BusinessJanuary 30, 2025 | finance.yahoo.comClarity Pharmaceuticals’ Groundbreaking Diagnostic Achievements in Prostate CancerJanuary 27, 2025 | tipranks.comGuess which ASX 200 biotech stock is jumping 15% on big US FDA newsJanuary 24, 2025 | msn.comClarity Pharmaceuticals: Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancerJanuary 24, 2025 | finanznachrichten.deClarity jumps as FDA awards fast track status for PET scan imaging agentJanuary 24, 2025 | msn.comClarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical ...January 24, 2025 | gurufocus.comClarity Pharmaceuticals Secures FDA Fast Track for Prostate Cancer Imaging AgentJanuary 23, 2025 | tipranks.comThis fund returned 109% in 2024. Here are 2 of its best-performing ASX sharesJanuary 22, 2025 | msn.comClarity Pharmaceuticals Issues New Shares Without DisclosureJanuary 22, 2025 | tipranks.comThe scientist-turned-banker’s mission to fund cancer breakthroughJanuary 10, 2025 | afr.comClarity Pharmaceuticals Updates on Securities CessationJanuary 8, 2025 | tipranks.comASX Market Close: Index pares gains to close flat | December 18, 2024December 18, 2024 | msn.comClarity Pharmaceuticals Lists New Securities on ASXDecember 18, 2024 | tipranks.comGuess which ASX healthcare stock is jumping 12% on WednesdayDecember 17, 2024 | msn.comWilsons Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)December 12, 2024 | markets.businessinsider.comClarity Pharmaceuticals Advances Radiopharmaceutical DiagnosticsNovember 27, 2024 | tipranks.comClarity Pharmaceuticals Director Increases Stock OptionsNovember 25, 2024 | tipranks.comClarity Pharmaceuticals Issues New Equity OptionsNovember 24, 2024 | tipranks.comClarity Pharmaceuticals Advances in Radiopharmaceutical InnovationsNovember 20, 2024 | markets.businessinsider.comClarity Pharmaceuticals Reports Successful AGM ResolutionsNovember 20, 2024 | markets.businessinsider.comClarity Pharmaceuticals Launches Promising Prostate Cancer TrialNovember 18, 2024 | markets.businessinsider.comClarity Pharmaceuticals Boosts Production with New AgreementsNovember 11, 2024 | markets.businessinsider.comClarity Pharmaceuticals Gains from New CMS Reimbursement RuleNovember 5, 2024 | markets.businessinsider.comClarity Pharmaceuticals Ltd's (ASX:CU6) top owners are individual investors with 58% stake, while 18% is held by insidersNovember 1, 2024 | finance.yahoo.comClarity Pharmaceuticals Issues New Employee Incentive OptionsNovember 1, 2024 | markets.businessinsider.comClarity Pharmaceuticals Expands Market Presence with New Share IssueOctober 28, 2024 | markets.businessinsider.comClarity Pharmaceuticals Expands Market Presence with New Share IssueOctober 28, 2024 | markets.businessinsider.comWhy Beach Energy, BSA, Clarity, and Perpetual shares are pushing higher todayOctober 17, 2024 | msn.comWhy this speculative ASX stock could rise ~50%October 17, 2024 | msn.comASX Market Close: Index ascends as Gold and Iron Ore rise | October 14, 2024October 14, 2024 | msn.comHealth Check: Thirsty Chimeric goes to the well for funding top-upOctober 13, 2024 | msn.comClarity Pharmaceuticals Ltd (CLRPF)October 4, 2024 | finance.yahoo.comAlive and Kicking: Prescient Therapeutics chief passes CEO baton after eight years in the jobSeptember 12, 2024 | msn.comUp 24% in a month! This ASX biotech share is hitting a record high on trial updateSeptember 12, 2024 | msn.comClarity Pharmaceuticals Ltd (CU6)September 11, 2024 | investing.comHere's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn SituationAugust 24, 2024 | finance.yahoo.comClarity Pharmaceuticals Ltd (CU6.AX)August 1, 2024 | finance.yahoo.comBroker urges investors to buy this ASX biotech stock for big returnsAugust 1, 2024 | msn.comTru Datt: When safe havens fail, head on down to the niche corners of the ASXJuly 29, 2024 | msn.comClarity Pharmaceuticals Ltd CU6July 27, 2024 | morningstar.com Get Clarity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CU6 and its competitors with MarketBeat's FREE daily newsletter. Email Address CU6 Media Mentions By Week CU6 Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CU6 News Sentiment▼0.610.60▲Average Medical News Sentiment CU6 News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CU6 Articles This Week▼31▲CU6 Articles Average Week Get Clarity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CU6 and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SWTX News Today OGN News Today RARE News Today PTCT News Today BHVN News Today VKTX News Today RNA News Today ADMA News Today ZLAB News Today ALVO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CU6) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarity Pharmaceuticals Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarity Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
